Immunovant halts CLE development after IMVT-1402 trial misses goal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| (NASDAQ: IMVT) | Delayed: 26.73 -0.78 (2.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.51 | 52 Week High | $ | |||
| Open | $27.42 | 52 Week Low | $ | |||
| Day High | $27.42 | P/E | N/A | |||
| Day Low | $26.28 | EPS | $ | |||
| Volume | 1,463,422 | |||||
| (NASDAQ: ROIV) | Delayed: 33.53 -0.51 (1.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.04 | 52 Week High | $ | |||
| Open | $34.12 | 52 Week Low | $ | |||
| Day High | $34.12 | P/E | N/A | |||
| Day Low | $33.23 | EPS | $ | |||
| Volume | 4,923,609 | |||||
